IL6 and ulcer disease: In addition, patients were followed up for 6 months after discharge, and long-term outcomes including ulcer recurrence, readmission, reoperation, and all-cause mortality were recorded.<h4>Results</h4>Before treatment, IL-6, TNF-α, and hs-CRP levels were similar in both groups.